Robert Doebler

Ohmx Corp. develops bioelectronic detection devices. Its products include biosensor chip, portable point-of-care (POC) system, and prostate cancer aggressiveness biomaker. The company was founded by Thomas J. Meade on October 25, 2004 and is headquartered in Evanston, IL.

Dxterity Diagnostics, Inc. develops simple and affordable genomic testing solutions for the research, diagnostic, and therapeutic markets. It offers direct to patient platform, digital recruitment, genomic services, and QSR product development. The company was founded by Robert Terbrueggen and Jim Healy in 2006 and is headquartered in Rancho Dominguez, CA.

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.

Part of Roche Holding AG, Clinical Micro Sensors, Inc. is a company that manufactures instruments used in genetic diagnostics testing. The company is based in Pasadena, CA. The company was founded by Jon Faiz Kayyem. Clinical Micro Sensors was acquired by Osmetech Ltd. from Motorola, Inc. on August 10, 2005 for $2.45 million.

Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA.

IncellDx, Inc. detects and monitors life threatening diseases. It offers transformative diagnostic and prognostic clinical patient information based on an innovative technology platform that enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers. The company was founded by Bruce K. Patterson and Carol Penfold-Patterson on December 3, 2009 and is headquartered in Menlo Park, CA.

RxDx Link operates as a consulting firm serving start-up, early stage, and mid-size biotechnology companies in the diagnostic, medical device and pharmaceutical industries. The company was founded by Christine A. Meda in 2007 and is headquartered in U.S.